|
Volumn 39, Issue SUPPL. B, 1997, Pages 57-62
|
The in-vitro activity of trovafloxacin, a new fluoroquinolone, against Gram-positive bacteria
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AGAR;
AMOXICILLIN;
BETA LACTAM ANTIBIOTIC;
CIPROFLOXACIN;
CLINDAMYCIN;
ERYTHROMYCIN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
TROVAFLOXACIN;
VANCOMYCIN;
ALPHA HEMOLYTIC STREPTOCOCCUS;
ANTIBIOTIC RESISTANCE;
ARTICLE;
BACTERICIDAL ACTIVITY;
BETA HEMOLYTIC STREPTOCOCCUS;
CONTROLLED STUDY;
DILUTION;
ENTEROCOCCUS FAECALIS;
GRAM POSITIVE BACTERIUM;
NONHUMAN;
STAPHYLOCOCCUS;
STRAIN DIFFERENCE;
STREPTOCOCCUS MILLERI;
STREPTOCOCCUS PNEUMONIAE;
ANTI-BACTERIAL AGENTS;
ANTI-INFECTIVE AGENTS;
CIPROFLOXACIN;
CLINDAMYCIN;
ERYTHROMYCIN;
FLUOROQUINOLONES;
GRAM-POSITIVE BACTERIA;
LACTAMS;
MICROBIAL SENSITIVITY TESTS;
NAPHTHYRIDINES;
VANCOMYCIN;
|
EID: 0030756870
PISSN: 03057453
EISSN: None
Source Type: Journal
DOI: 10.1093/jac/39.suppl_2.57 Document Type: Article |
Times cited : (29)
|
References (6)
|